Clinical Diagnostics & Liquid Biopsy

Uncover the future of clinical diagnostics with innovations in liquid biopsy and non-invasive monitoring that are reshaping how we detect, track, and treat disease.

Advanced Liquid Biopsy for Mutation and Methylation Detection in Cancer

Applications of ctDNA in Drug Development

Point-of-Care Digital Detection of Molecular Biomarkers and Viruses

Nursing And Midwifery In The Genomics Era

How The SWAN Clinic Is Changing Rare Disease Care

SWAN: Clinical Genomics for Diagnosing Rare Genetic Diseases

The 6 Ps Of Multiomic Medicine

Towards Clinical Genomics for All in Nursing and Midwifery

Nipping Pancreatic Cancer In The Bud: The Promise of Liquid Biopsy Diagnostics

Reinventing the Wheel with Computational Pathology

Advancing Liquid Biopsies for Clinical Use

Accelerating the Adoption of Liquid Biopsy in the Clinic

Current Landscape Of Liquid Biopsies: Lessons From Clinical Trials

Liquid Insights: Therapy Wins and Warnings in Lung Cancer

Using Liquid Biopsy Where It Matters Most—Disease Progression

Advancements and Trends in NGS for Liquid Biopsies

Looking into the Future of Cytology and AI

Predicting Lung Cancer Response with B Cell Biomarkers

Detecting Bladder Cancer With Urinary TERT Promoter Mutations

Diagnosing and Monitoring Lung Cancer Using Clinical ctDNA dPCR and Liquid Biopsy

cfDNA Methylation Profiling with Liquid Biopsy in Small Cell Lung Cancer

Beating the Diagnostic Odyssey With The 100,000 Genomes Project